These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27096781)

  • 1. Rush sublingual immunotherapy in canine atopic dermatitis: a prospective pilot study.
    Fujimura M; Ishimaru H
    Pol J Vet Sci; 2016; 19(1):3-6. PubMed ID: 27096781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immunological responses of dust mite sensitive, atopic dogs to treatment with sublingual immunotherapy (SLIT).
    DeBoer DJ; Verbrugge M; Morris M
    Vet Dermatol; 2016 Apr; 27(2):82-7e23. PubMed ID: 26749020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double blind, randomized, placebo controlled trial of the efficacy, quality of life and safety of food allergen-specific sublingual immunotherapy in client owned dogs with adverse food reactions: a small pilot study.
    Maina E; Cox E
    Vet Dermatol; 2016 Oct; 27(5):361-e91. PubMed ID: 27426929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.
    Mueller RS; Veir J; Fieseler KV; Dow SW
    Vet Dermatol; 2005 Feb; 16(1):61-8. PubMed ID: 15725107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long-term control of dogs with nonseasonal atopic dermatitis.
    Fischer NM; Rostaher A; Favrot C
    Vet Dermatol; 2020 Oct; 31(5):365-e96. PubMed ID: 32537789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of rush immunotherapy with alum-precipitated allergens in canine atopic dermatitis.
    Hobi S; Mueller RS
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2014; 42(3):167-73. PubMed ID: 24920143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A Treatment in Intrinsic Canine Atopic Dermatitis (Atopic-like Dermatitis): Open Trial Study.
    Fujimura M; Nakatsuji Y; Ishimaru H
    Pol J Vet Sci; 2016 Sep; 19(3):567-572. PubMed ID: 27760033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study.
    Cadario G; Galluccio AG; Pezza M; Appino A; Milani M; Pecora S; Mastrandrea F
    Curr Med Res Opin; 2007 Oct; 23(10):2503-6. PubMed ID: 17784996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and clinical efficacy of oral immunotherapy with house dust mites in a model of canine atopic dermatitis: a pilot study.
    Marsella R
    Vet Dermatol; 2010 Dec; 21(6):566-71. PubMed ID: 20492623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.
    Nuttall TJ; McEwan NA; Bensignor E; Cornegliani L; Löwenstein C; Rème CA
    Vet Dermatol; 2012 Feb; 23(1):4-10, e1-2. PubMed ID: 21718368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.
    Nuttall T; Mueller R; Bensignor E; Verde M; Noli C; Schmidt V; Rème C
    Vet Dermatol; 2009 Jun; 20(3):191-8. PubMed ID: 19374721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega.
    Litzlbauer P; Weber K; Mueller RS
    Cytokine; 2014 Mar; 66(1):54-9. PubMed ID: 24548425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study.
    Ferguson EA; Littlewood JD; Carlotti DN; Grover R; Nuttall T
    Vet Dermatol; 2006 Aug; 17(4):236-43. PubMed ID: 16827666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intralymphatic immunotherapy: An effective and safe alternative route for canine atopic dermatitis].
    Fischer N; Rostaher A; Favrot C
    Schweiz Arch Tierheilkd; 2016 Sep; 158(9):646-652. PubMed ID: 27655164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of the effect of pullulan-conjugated Der f 2 allergen-specific immunotherapy on canine atopic dermatitis.
    Kawano K; Mizuno T
    Vet Dermatol; 2017 Dec; 28(6):583-e141. PubMed ID: 28776792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatophagoides farinae-specific immunotherapy in atopic dogs with hypersensitivity to multiple allergens: a randomised, double blind, placebo-controlled study.
    Willemse T; Bardagi M; Carlotti DN; Ferrer L; Fondati A; Fontaine J; Leistra M; Noli C; Ordeix L; Scarampella F; Schleifer S; Sinke J; Roosje P
    Vet J; 2009 Jun; 180(3):337-42. PubMed ID: 18653361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs.
    Olivry T; Saridomichelakis M; Nuttall T; Bensignor E; Griffin CE; Hill PB;
    Vet Dermatol; 2014 Apr; 25(2):77-85, e25. PubMed ID: 24461108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the safety of an abbreviated course of injections of allergen extracts (rush immunotherapy) for the treatment of dogs with atopic dermatitis.
    Mueller RS; Bettenay SV
    Am J Vet Res; 2001 Mar; 62(3):307-10. PubMed ID: 11277192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial.
    Cadot P; Hensel P; Bensignor E; Hadjaje C; Marignac G; Beco L; Fontaine J; Jamet JF; Georgescu G; Campbell K; Cannon A; Osborn SC; Messinger L; Gogny-Goubert M; Dubreuil P; Moussy A; Hermine O
    Vet Dermatol; 2011 Dec; 22(6):554-64. PubMed ID: 21668810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of immunotherapy in dogs with atopic dermatitis using a mannan-Dermatophagoides farinae allergoid targeting dendritic cells.
    González JL; Zalve V; Fernández-Caldas E; Cases B; Subiza JL; Casanovas M
    Vet Dermatol; 2018 Oct; 29(5):449-e152. PubMed ID: 30183126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.